Further support to a role of GALNT2 as a mediator of intermediate metabolism comes from studies showing that genetic variability at the GALNT2 locus is associated with HDL-c and triglycerides levels [16], [17], [18], two main components of the insulin resistance/metabolic syndrome. This evidence concerns the gene GALNT2 and Insulin resistance.